Back to Knott David M Jr

Knott David M Jr

All holdings · as of Dec 31, 2025

87 positions

CompanyClassValueShares% of portfolio
Calumet, Inc. /DE$44.01M2,214,96920.4%
Apollo Global Management, Inc.$32.57M225,00015.1%
Alphabet Inc.$28.69M91,42013.3%
Syndax Pharmaceuticals Inc$8.72M415,0004.0%
Xeris Biopharma Holdings, Inc.$7.61M970,0003.5%
Travere Therapeutics, Inc.$7.11M186,0003.3%
BridgeBio Pharma, Inc.$6.50M85,0003.0%
PROTAGONIST THERAPEUTICS INC$6.38M73,0003.0%
JPMORGAN CHASE & CO$6.28M19,4772.9%
Janus Henderson AAA CLO ETF$4.73M93,5282.2%
Viridian Therapeutics, Inc.$4.51M145,0002.1%
CATALYST PHARMACEUTICALS, INC.$4.41M189,0002.0%
Cogent Biosciences, Inc.$3.62M102,0001.7%
Arcus Biosciences, Inc.$2.89M121,2411.3%
Alkermes plc.$2.66M95,0001.2%
DocGo Inc$2.34M2,670,8501.1%
Cybin Inc.$2.33M285,1821.1%
Cytokinetics Inc$2.16M34,0001.0%
AtriCure Inc$2.03M51,4000.9%
ALLIANCEBERNSTEIN HOLDING L.P.ABMLP$1.85M48,0000.9%
Arcellx Inc$1.68M25,7000.8%
SPDR S&P Biotech ETF$1.59M13,0000.7%
Tectonic Therapeutic, Inc.TECXCommon Stock$1.54M74,0000.7%
Wave Life Science Ltd.$1.53M90,0000.7%
JOHNSON & JOHNSON$1.43M6,9220.7%
TG Therapeutics Inc$1.34M45,0000.6%
Vera Therapeutics, Inc.$1.32M26,0000.6%
The Panagram BBB-B CLO ETF$1.27M47,8070.6%
Biohaven Ltd.$1.25M110,7200.6%
BRISTOL MYERS SQUIBB CO$1.19M22,0000.5%
MADRIGAL PHARMACEUTICALS, INC.$1.16M2,0000.5%
ADMA Biologics Inc$1.10M60,2000.5%
BIOGEN INC.$1.06M6,0000.5%
Orchestra BioMed Holdings, Inc.OBIOCommon Stock$1.04M250,0000.5%
iShares Biotechnology ETF$928.2K5,5000.4%
Solid Biosciences Inc.SLDBCommon Stock$916.2K162,4400.4%
LENZ Therapeutics, Inc.$859.7K53,7320.4%
PFIZER INC$805.2K32,3370.4%
Rezolute, Inc.$802.4K340,0000.4%
MICROSOFT CORP$773.8K1,6000.4%
Apple Inc.$678.0K2,4940.3%
Evolus, Inc.$660.6K99,3380.3%
NEKTAR THERAPEUTICS$655.3K15,5000.3%
INTERNATIONAL BUSINESS MACHINES CORP$634.5K2,1420.3%
Scholar Rock Holding Corp$612.9K13,9130.3%
Pelthos Therapeutics Inc.PTHSCommon Stock$597.7K19,2810.3%
Canadian Natural Resources Limited$568.7K16,8000.3%
Connect Biopharma Holdings Limited$564.0K200,0000.3%
Xenon Pharmaceuticals Inc.$491.3K10,9620.2%
AGIOS PHARMACEUTICALS, INC.$490.0K18,0000.2%
← PrevPage 1 of 2Next →